Beijing Kawin Technology Share-Holding Co., Ltd.

Company Profile
Beijing Kawin Technology Share-Holding Co., Ltd.
Focusing on viral and immune diseases, Kawin can offer matured products based upon our specialty in interferon strain management, in EP standard. We also can provide product licensing opportunities like our portfolio of Glycyrrhizin products that have been popularized in dermatology and hepatology. Transfer of Interferon & GCSF (both conventional & pegylated), and kinds of mAbs (Nivolumab) are also open to discussion.
more >

Year of Establishment: 2008

Total Assets(USD):

Total Number of Staff:

Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    Beijing Kawin Technology Share-Holding Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service